Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1994 Mar;144(3):473–479.

Divergent expression of EtA and EtB receptors in response to cyclosporine in mesangial cells.

M Takeda 1, S Iwasaki 1, S E Hellings 1, H Yoshida 1, T Homma 1, V Kon 1
PMCID: PMC1887079  PMID: 8129032

Abstract

We examined the effects of cyclosporine (Cy) on preproendothelin-1 (prepro Et-1) and both Et receptors, A-type (EtA) and B-type (EtB), in rat glomerular mesangial cells. Cy at 10(-5) mol/L, the concentration relevant to tissue levels in vivo, increased mRNA for prepro Et-1 after both 1 and 3 hours to 183 +/- 14% (n = 8) and 147 +/- 12% (n = 9) of levels seen in control cells. A similar pattern was observed at a lower dose of Cy (10(-6) mol/L, the concentration relevant to plasma levels in vivo): at 1 hour, expression increased to 146 +/- 15% (n = 5); at 3 hours, expression was 159 +/- 25% (n = 8). Concomitant with these changes in expression of prepro Et-1 mRNA, the Et-1 protein nearly doubled at 3 hours. Both EtA and EtB mRNA were expressed in unstimulated mesangial cells and were affected differently by Cy. Little change was observed in the EtA mRNA. In contrast, EtB mRNA increased with Cy (10(-5) mol/L) up to 129 +/- 8% (n = 6) at 1 hour and 265 +/- 62% (n = 3) at 3 hours. A similar effect was seen with the lower dose of Cy: EtB expression increased to 129 +/- 9% (n = 6) of control value at 1 hour and 253 +/- 74% (n = 4) at 3 hours. These results indicate that Cy enhances expression of mRNA for prepro Et-1 and production of mature Et-1 by glomerular mesangial cells. Further, Cy has differential effects on EtA and EtB, affecting EtA minimally while markedly increasing the expression of EtB. These results constitute the first demonstration that Et receptor subtypes are modulated in a pathophysiological setting. The divergent modulation of EtA and EtB raises the possibility that there are differences in contribution of each of the receptor subtypes to pathophysiological mechanisms of Cy toxicity.

Full text

PDF
473

Images in this article

476Figure 1
on p.476
476Figure 2
on p.476

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990 Dec 20;348(6303):730–732. doi: 10.1038/348730a0. [DOI] [PubMed] [Google Scholar]
  2. Awazu M., Sugiura M., Inagami T., Ichikawa I., Kon V. Cyclosporine promotes glomerular endothelin binding in vivo. J Am Soc Nephrol. 1991 May;1(11):1253–1258. doi: 10.1681/ASN.V1111253. [DOI] [PubMed] [Google Scholar]
  3. Bunchman T. E., Brookshire C. A. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest. 1991 Jul;88(1):310–314. doi: 10.1172/JCI115293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  5. Eguchi S., Hirata Y., Imai T., Marumo F. Endothelin receptor subtypes are coupled to adenylate cyclase via different guanyl nucleotide-binding proteins in vasculature. Endocrinology. 1993 Feb;132(2):524–529. doi: 10.1210/endo.132.2.7678793. [DOI] [PubMed] [Google Scholar]
  6. Fogo A., Hellings S. E., Inagami T., Kon V. Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Kidney Int. 1992 Sep;42(3):770–774. doi: 10.1038/ki.1992.346. [DOI] [PubMed] [Google Scholar]
  7. Hirata Y., Emori T., Eguchi S., Kanno K., Imai T., Ohta K., Marumo F. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest. 1993 Apr;91(4):1367–1373. doi: 10.1172/JCI116338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hori S., Komatsu Y., Shigemoto R., Mizuno N., Nakanishi S. Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology. 1992 Apr;130(4):1885–1895. doi: 10.1210/endo.130.4.1312429. [DOI] [PubMed] [Google Scholar]
  9. Kon V., Sugiura M., Inagami T., Harvie B. R., Ichikawa I., Hoover R. L. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int. 1990 Jun;37(6):1487–1491. doi: 10.1038/ki.1990.139. [DOI] [PubMed] [Google Scholar]
  10. Krapf R., Solioz M. Na/H antiporter mRNA expression in single nephron segments of rat kidney cortex. J Clin Invest. 1991 Sep;88(3):783–788. doi: 10.1172/JCI115377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lanese D. M., Conger J. D. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest. 1993 May;91(5):2144–2149. doi: 10.1172/JCI116440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lin H. Y., Kaji E. H., Winkel G. K., Ives H. E., Lodish H. F. Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3185–3189. doi: 10.1073/pnas.88.8.3185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Liu J. J., Casley D. J., Nayler W. G. Ischaemia causes externalization of endothelin-1 binding sites in rat cardiac membranes. Biochem Biophys Res Commun. 1989 Nov 15;164(3):1220–1225. doi: 10.1016/0006-291x(89)91799-3. [DOI] [PubMed] [Google Scholar]
  14. Nakahama H. Stimulatory effect of cyclosporine A on endothelin secretion by a cultured renal epithelial cell line, LLC-PK1 cells. Eur J Pharmacol. 1990 May 3;180(1):191–192. doi: 10.1016/0014-2999(90)90610-i. [DOI] [PubMed] [Google Scholar]
  15. Nambi P., Pullen M., Contino L. C., Brooks D. P. Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity. Eur J Pharmacol. 1990 Oct 2;187(1):113–116. doi: 10.1016/0014-2999(90)90346-8. [DOI] [PubMed] [Google Scholar]
  16. Pollock D. M., Opgenorth T. J. Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation. Am J Physiol. 1993 Jan;264(1 Pt 2):R222–R226. doi: 10.1152/ajpregu.1993.264.1.R222. [DOI] [PubMed] [Google Scholar]
  17. Rodríguez-Puyol D., Lamas S., Olivera A., López-Farré A., Ortega G., Hernando L., López-Novoa J. M. Actions of cyclosporin A on cultured rat mesangial cells. Kidney Int. 1989 Feb;35(2):632–637. doi: 10.1038/ki.1989.32. [DOI] [PubMed] [Google Scholar]
  18. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990 Dec 20;348(6303):732–735. doi: 10.1038/348732a0. [DOI] [PubMed] [Google Scholar]
  19. Sumner M. J., Cannon T. R., Mundin J. W., White D. G., Watts I. S. Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction. Br J Pharmacol. 1992 Nov;107(3):858–860. doi: 10.1111/j.1476-5381.1992.tb14537.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Takeda M., Breyer M. D., Noland T. D., Homma T., Hoover R. L., Inagami T., Kon V. Endothelin-1 receptor antagonist: effects on endothelin- and cyclosporine-treated mesangial cells. Kidney Int. 1992 Jun;41(6):1713–1719. doi: 10.1038/ki.1992.245. [DOI] [PubMed] [Google Scholar]
  21. Takeda M., Homma T., Breyer M. D., Horiba N., Hoover R. L., Kawamoto S., Ichikawa I., Kon V. Volume and agonist-induced regulation of myosin light-chain phosphorylation in glomerular mesangial cells. Am J Physiol. 1993 Mar;264(3 Pt 2):F421–F426. doi: 10.1152/ajprenal.1993.264.3.F421. [DOI] [PubMed] [Google Scholar]
  22. Terada Y., Tomita K., Nonoguchi H., Marumo F. Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay. J Clin Invest. 1992 Jul;90(1):107–112. doi: 10.1172/JCI115822. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES